{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T10:17:58Z","timestamp":1693045078680},"reference-count":16,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.vaccine.2009.02.055","type":"journal-article","created":{"date-parts":[[2009,2,25]],"date-time":"2009-02-25T05:35:12Z","timestamp":1235540112000},"page":"3223-3227","source":"Crossref","is-referenced-by-count":4,"title":["Analysis of mortality following a mass immunization campaign with serogroup C meningococcal conjugate vaccine: Methodological difficulties and imperfect solutions"],"prefix":"10.1016","volume":"27","author":[{"given":"Philippe","family":"De Wals","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Deceuninck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manale","family":"Ouakki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Boulianne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaston","family":"De Serres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Danzig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.02.055_bib1","series-title":"Vaccines","first-page":"1557","article-title":"Safety of immunizations","author":"Chen","year":"2004"},{"key":"10.1016\/j.vaccine.2009.02.055_bib2","series-title":"New generation vaccines","first-page":"19","article-title":"Initial clinical evaluation of new vaccine candidates: investigators\u2019 perspective of phase I and phase II clinical trials of safety, immunogenicity, and preliminary efficacy","author":"Tacket","year":"2004"},{"key":"10.1016\/j.vaccine.2009.02.055_bib3","series-title":"New generation vaccines","first-page":"29","article-title":"Long-term evaluation of vaccine protection: methodological issues for phase III and phase IV studies","author":"Clemens","year":"2004"},{"key":"10.1016\/j.vaccine.2009.02.055_bib4","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1128\/JCM.42.4.1460-1465.2004","article-title":"Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C:2a:P1.7,1) causing invasive meningococcal disease in Quebec, Canada","volume":"42","author":"Tsang","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2009.02.055_bib5","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1001\/jama.292.20.2491","article-title":"Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine","volume":"292","author":"De Wals","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.02.055_bib6","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1086\/428729","article-title":"Effectiveness of serogroup C meningococcal polysaccharide vaccine: results from a case-control study in Quebec","volume":"40","author":"De Wals","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.055_bib7","first-page":"2","article-title":"Statement on recommended use of meningococcal vaccines","volume":"27 (ACS\u20135, 6)","author":"National Advisory Committee on Immunization (NACI)","year":"2001","journal-title":"CCDR"},{"key":"10.1016\/j.vaccine.2009.02.055_bib8","series-title":"Vaccines","first-page":"959","article-title":"Meningococcal vaccines","author":"Granoff","year":"2004"},{"key":"10.1016\/j.vaccine.2009.02.055_bib9","series-title":"Modern epidemiology","first-page":"115","article-title":"Precision and validity in epidemiologic studies","author":"Rothman","year":"1998"},{"key":"10.1016\/j.vaccine.2009.02.055_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/oxfordjournals.aje.a116479","article-title":"Confounding in studies of adverse reactions to vaccines","volume":"136","author":"Fine","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2009.02.055_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1749-6632.1995.tb44463.x","article-title":"Methodological issues in the evaluation and monitoring of vaccine safety","volume":"754","author":"Fine","year":"1995","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.vaccine.2009.02.055_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ije\/dyi274","article-title":"Evidence in bias in estimates of influenza vaccine effectiveness in seniors","volume":"35","author":"Jackson","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2009.02.055_bib13","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/oxfordjournals.aje.a008695","article-title":"Case series analysis of adverse reactions to vaccines: a comparative evaluation","volume":"143","author":"Farrington","year":"1966","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2009.02.055_bib14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/oxfordjournals.aje.a113809","article-title":"An epidemiologic and clinical evaluation of Guillain\u2013Barr\u00e9 syndrome reported in association with the administration of swine influenza vaccines","volume":"119","author":"Langmuir","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2009.02.055_bib15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"334","author":"Murphy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.02.055_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/qre.493","article-title":"EWMA techniques for computer intrusion detection through anomalous changes in event intensity","volume":"18","author":"Ye","year":"2002","journal-title":"Qual Reliab Eng Int"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T03:55:10Z","timestamp":1558151710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09003004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":16,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0264410X09003004"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}